Free Trial
OTCMKTS:CMPD

CompuMed (CMPD) Stock Price, News & Analysis

CompuMed logo
$3.98 0.00 (0.00%)
As of 05/27/2025

About CompuMed Stock (OTCMKTS:CMPD)

Key Stats

Today's Range
$3.98
$3.98
50-Day Range
$2.90
$3.99
52-Week Range
$1.80
$6.80
Volume
N/A
Average Volume
3,634 shs
Market Capitalization
$5.28 million
P/E Ratio
23.41
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

CompuMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

CMPD MarketRank™: 

CompuMed scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CompuMed.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CompuMed is 23.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CompuMed is 23.41, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.89.

  • Price to Book Value per Share Ratio

    CompuMed has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CompuMed's valuation and earnings.
  • Percentage of Shares Shorted

    0.48% of the float of CompuMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CompuMed has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    CompuMed does not currently pay a dividend.

  • Dividend Growth

    CompuMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.48% of the float of CompuMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CompuMed has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • MarketBeat Follows

    1 people have added CompuMed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CompuMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.00% of the stock of CompuMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CompuMed's insider trading history.
Receive CMPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter.

CMPD Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
CMPD to discuss theft ring case
Compumed Inc.
See More Headlines

CMPD Stock Analysis - Frequently Asked Questions

CompuMed's stock was trading at $3.81 on January 1st, 2025. Since then, CMPD stock has increased by 4.5% and is now trading at $3.98.
View the best growth stocks for 2025 here
.

CompuMed, Inc. (OTCMKTS:CMPD) issued its earnings results on Monday, December, 16th. The company reported $0.02 earnings per share (EPS) for the quarter. CompuMed had a trailing twelve-month return on equity of 6.96% and a net margin of 3.44%.

CompuMed shares reverse split before market open on Saturday, May 21st 2022. The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM).

Company Calendar

Last Earnings
12/16/2024
Today
5/29/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Data processing & preparation
Sub-Industry
Business Services
Current Symbol
OTCMKTS:CMPD
CIK
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
23.41
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$190 thousand
Pretax Margin
2.29%

Debt

Sales & Book Value

Annual Sales
$6.22 million
Cash Flow
$0.55 per share
Price / Cash Flow
7.24
Book Value
$2.42 per share
Price / Book
1.64

Miscellaneous

Free Float
1,034,000
Market Cap
$5.28 million
Optionable
Not Optionable
Beta
-0.02
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:CMPD) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners